Profile of Enfortumab Vedotin in the Treatment of Urothelial Carcinoma: The Evidence to Date

by Moussa M, Papatsoris A, Abou Chakra M, Dellis A
Published 2021-02-01

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook

by Gopalakrishnan D, Koshkin VS, Ornstein MC, Papatsoris A, Grivas P
Published 2018-06-01

Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes

by Dellis A, Zakopoulou R, Kougioumtzopoulou A, Tzannis K, Koutsoukos K, Fragkoulis C, Kostouros E, Papatsoris A, Varkarakis I, Stravodimos K, Boutati E, Pagoni S, Seferlis M, Chrisofos M, Kouloulias V, Ntoumas K, Deliveliotis C, Constantinides C, Dimopoulos MA, Bamias A
Published 2021-07-01